Close Menu

NEW YORK ─ Access Genetics, doing business as OralDNA Labs, said on Wednesday that the US Food and Drug Administration has issued an amended Emergency Use Authorization for its OraRisk COVID-19 RT-PCR test, allowing testing from the collection of a saline oral rinse.

The test enables the detection of nucleic acid from SARS-CoV-2 in saline oral rinse specimens, nasopharyngeal swabs, and nasal swabs collected in universal transport media, as well as nasal swabs collected in saline oral rinse from people suspected of COVID-19 by their healthcare provider.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.